ClinicalTrials.Veeva

Menu
J

Jefferson Health | Einstein Medical Center Philadelphia - Klein Building - Rheumatology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

AB-101
Calaspargase Pegol

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

AB-101 is an off-the shelf, allogeneic cell product made of "natural killer" cells, also called NK cells. White blood cells are part of the immune sy...

Enrolling
Non Hodgkin Lymphoma
Drug: Interleukin-2
Drug: Rituximab

The purpose of this phase 2/3 study is to confirm the recommended doses and to evaluate the safety and pharmacodynamics of Calaspargase pegol for the...

Enrolling
Acute Lymphoblastic Leukemia
Drug: Calaspargase pegol (S95015)

Trial sponsors

A
Friends Research Institute logo
Servier logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems